12 Health Care Stocks Moving In Tuesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Tuesday's after-market session, several healthcare stocks showed significant movement. NKGen Biotech led the gainers with a 62.4% increase, while Heart Test Laboratories experienced the largest drop among the losers, decreasing by 22.2%. Notably, companies like Cerus, Sophia Genetics, and Marinus Pharma released their Q4 earnings, influencing their stock prices.
March 05, 2024 | 9:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cerus' stock rose by 9.09% to $2.16 after releasing Q4 earnings, with a market cap of $391.3 million.
The increase in Cerus' stock price post-Q4 earnings announcement indicates a positive market response to the financial results, suggesting potential short-term growth.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 80
POSITIVE IMPACT
NKGen Biotech's stock surged 62.4% to $1.4, with a market cap of $30.6 million.
The substantial increase in NKGen Biotech's stock price likely reflects positive investor sentiment or reactions to recent company developments, potentially making it an attractive short-term investment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Sophia Genetics' stock increased by 7.32% to $6.01 after Q4 earnings, with a market cap of $391.4 million.
Sophia Genetics' stock price uplift following their Q4 earnings report suggests investor confidence in the company's financial health, indicating a positive short-term outlook.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 80
NEGATIVE IMPACT
Heart Test Laboratories' stock plummeted by 22.2% to $0.14, with a market cap of $8.8 million.
The significant drop in Heart Test Laboratories' stock price suggests negative market reaction, possibly due to disappointing news or earnings, making it a risky short-term investment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Marinus Pharma's stock fell by 12.56% to $8.08 after their Q4 earnings, with a market cap of $440.9 million.
The decline in Marinus Pharma's stock price after the Q4 earnings release suggests the market reacted negatively to the financial results, indicating potential short-term risk.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 80